# CARsgen Therapeutics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carsgen-therapeutics-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.carsgen.com
- Total disclosed funding: $286M
- Latest round: Series C (Jan 15, 2021)
- Investors on record: 12

## About

Established in 2014 and based in Shanghai, China, CARsgen Therapeutics Co., Ltd. operates as a biopharmaceutical company that focuses on chimeric antigen receptor t-cell(CAR-T) cell therapy to treat hematomas and solid tumors.

The company provides cell therapy platform that includes target discovery, lead antibody development, clinical research and commercial scale production. The product of the company includes manand biosphere programme(mAb) and the regular, next generation and Allogeneic of cell therapy products, such as AB011, KJ-C2112 and CT011. The company develops cytokine and chemokine loaded CAR(CycloCAR), target to hinder the attack of nk cell(THANK)-uCAR and whole human anti-phage display technology. The company has 7 investigational new drug(IND)licenses.

## Funding rounds

- Series C, Jan 15, 2021, $10M — Hillhouse Investment
- Series C, Nov 2, 2020, $186M — Lilly Asia Ventures, South China Venture Capital, Loyal Valley Capital, Summer Capital, Shiyu Capital
- Series B, Mar 2, 2018, $60M — Photon Fund
- Series B, Jan 25, 2016, $30M — WOORI Venture Partners, Kaitai Capital, Jolly Innovation Ventures, JIC GenesisFountain Healthcare Ventures
- Series A, Nov 26, 2014 — BVCF Capital

## Investors

- BVCF Capital — Series A
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series B
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series B
- Jolly Innovation Ventures — Series B
- JIC GenesisFountain Healthcare Ventures — Series B
- Photon Fund (https://capitalatlas.ai/funds/photon-fund) — Series B
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series C
- South China Venture Capital (https://capitalatlas.ai/funds/south-china-venture-capital) — Series C
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series C
- Summer Capital — Series C
- Shiyu Capital (https://capitalatlas.ai/funds/shiyu-capital) — Series C
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series C